New patent expiration for Janssen Prods drug SYMTUZA
Annual Drug Patent Expirations for SYMTUZA Symtuza is a drug marketed by Janssen Prods and is included in one NDA. […]
New patent expiration for Janssen Prods drug SYMTUZA Read Post »
Annual Drug Patent Expirations for SYMTUZA Symtuza is a drug marketed by Janssen Prods and is included in one NDA. […]
New patent expiration for Janssen Prods drug SYMTUZA Read Post »
Annual Drug Patent Expirations for BIKTARVY Biktarvy is a drug marketed by Gilead Sciences Inc and is included in one
New patent expiration for Gilead Sciences drug BIKTARVY Read Post »
Annual Drug Patent Expirations for CAMPTOSAR Camptosar is a drug marketed by Pfizer Inc and is included in one NDA.
New patent expiration for Pfizer Inc drug CAMPTOSAR Read Post »
Annual Drug Patent Expirations for CRESEMBA Cresemba is a drug marketed by Astellas and is included in two NDAs. It
New patent expiration for Astellas drug CRESEMBA Read Post »
Annual Drug Patent Expirations for VEREGEN Veregen is a drug marketed by Fougera Pharms Inc and is included in one
New patent expiration for Fougera Pharms drug VEREGEN Read Post »
Annual Drug Patent Expirations for HYSINGLA+ER Hysingla Er is a drug marketed by Purdue Pharma Lp and is included in
New patent expiration for Purdue Pharma drug HYSINGLA ER Read Post »
METADATE CD (methylphenidate hydrochloride) Lannett co inc Patent: 6,344,215 Expiration: Oct 27, 2020 See More … For more information on
Drug Patent Expirations for the Week of October 25, 2020 Read Post »
Annual Drug Patent Expirations for SPRYCEL Sprycel is a drug marketed by Bristol Myers Squibb and is included in one
New patent expiration for Bristol Myers drug SPRYCEL Read Post »
Annual Drug Patent Expirations for CAMPTOSAR Camptosar is a drug marketed by Pfizer Inc and is included in one NDA.
New patent expiration for Pfizer Inc drug CAMPTOSAR Read Post »
Get fresh news and insights, drug patent expirations & more…